Annual report [Section 13 and 15(d), not S-K Item 405]

Stockholders??? (Deficit) Equity (Details)

v3.25.1
Stockholders’ (Deficit) Equity (Details) - USD ($)
1 Months Ended 12 Months Ended
Jul. 11, 2023
Jul. 31, 2021
Dec. 31, 2024
Dec. 19, 2024
Dec. 18, 2024
Dec. 11, 2024
Oct. 31, 2024
Oct. 09, 2024
Aug. 14, 2024
Jul. 29, 2024
Jul. 25, 2024
Jul. 23, 2024
Jul. 05, 2024
Jun. 25, 2024
Mar. 26, 2024
Dec. 31, 2023
Stockholders’ Equity [Line Items]                                
Common stock, shares authorized     400,000,000                         200,000,000
Common stock, par value (in Dollars per share)     $ 0.001                         $ 0.001
Common stock share issued     113,842,364                         34,756,049
Common stock price (in Dollars per share)   $ 5 $ 1,000                          
Shares of common stock 43,649   736,773                          
Convertible debt shares granted     184,193                          
Warrant [Member]                                
Stockholders’ Equity [Line Items]                                
Shares warrants   4,000,000                            
Common stock price (in Dollars per share)   $ 0.0125                            
Warrants term   5 years 5 years                          
Exercise price per warrant (in Dollars per share)   $ 6 $ 6                          
Purchase of additional warrants   600,000                            
Proceeds of warrants (in Dollars)   $ 7,500                            
Common Stock [Member]                                
Stockholders’ Equity [Line Items]                                
Common stock price (in Dollars per share)   $ 4.99                            
Shares of common stock 43,502,206                              
Conversion of the shares series preferred stock 19,516,205                              
Series A-2 Preferred Stock [Member]                                
Stockholders’ Equity [Line Items]                                
Common stock share issued           7,863,327   5,500,000 3,502,000 1,359,000 3,756,000 3,550,000   5,956,000 2,850,000  
Conversion of the shares series preferred stock 43,649         3,853.03   2,695 1,715.98 665.91 1,840.44 1,739.5   2,918.44 1,396.5  
Series B-2 Preferred Stock [Member]                                
Stockholders’ Equity [Line Items]                                
Common stock share issued       3,003,000 1,441,000   438,000           42,118,000      
Conversion of the shares series preferred stock       3,003 1,441   438           7,882      
IPO [Member]                                
Stockholders’ Equity [Line Items]                                
Common stock share issued   5,000,000